These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3293493)

  • 1. A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome.
    Freundlich B; Makover D; Maul GG
    Ann Intern Med; 1988 Aug; 109(4):295-7. PubMed ID: 3293493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of antinuclear antibodies in systemic lupus erythematosus.
    Liu HW; Chi CY; Lin SF; Tsai JH; Chen CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):135-45. PubMed ID: 7026188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 4. Class specific antinuclear antibodies in systemic lupus erythematosus.
    Savitri K; Sehgal S; Datta BN; Chugh KS
    Indian J Med Res; 1993 Feb; 98():27-9. PubMed ID: 8495986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen.
    Winn DM; Wolfe JF; Lindberg DA; Fristoe FH; Kingsland L; Sharp GC
    Arthritis Rheum; 1979 Dec; 22(12):1334-7. PubMed ID: 391237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus erythematosus cell preparation, antinuclear factor and antideoxyribonucleic acid antibody incongruity in systemic lupus erythematosus.
    Chee YC
    Ann Acad Med Singap; 1983 Jan; 12(1):109-14. PubMed ID: 6190427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus presenting as chronic serositis with no demonstrable antinuclear antibodies.
    Ferreiro JE; Reiter WM; Saldana MJ
    Am J Med; 1984 Jun; 76(6):1100-5. PubMed ID: 6610353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Raynaud's phenomenon in a patient with antinuclear antibody-negative systemic lupus erythematosus.
    Maxwell CJ; Potter E; Townsend J
    J Natl Med Assoc; 1988 May; 80(5):594-5. PubMed ID: 3262169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human antinuclear antibodies on rodent omenta.
    Holub M
    Allerg Immunol (Leipz); 1982; 28(2):118-21. PubMed ID: 6182782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus and Raynaud's phenomenon.
    Heimovski FE; Simioni JA; Skare TL
    An Bras Dermatol; 2015; 90(6):837-40. PubMed ID: 26734864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Antinuclear antibodies-clinical significance of the nuclear immunofluorescent patterns.
    Burnham TK; Bank PW
    Am J Clin Pathol; 1975 Aug; 64(2):289-90. PubMed ID: 1098444
    [No Abstract]   [Full Text] [Related]  

  • 14. [Symposium on autoimmune diseases. 3. Pathogenetic significance of antinuclear factor in systemic lupus erythematosus].
    Ofuji T
    Nihon Naika Gakkai Zasshi; 1972 Jun; 61(6):583-7. PubMed ID: 4565165
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome.
    De Giorgio CM; Rabinowicz AL; Olivas RD
    Epilepsia; 1991; 32(1):128-9. PubMed ID: 1985821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Connective tissue diseases and HEp-2 antinuclear antibodies].
    Scagliusi P; Anelli P; Fasiello V; De Lucia M; Pipitone V
    Minerva Med; 1985 May; 76(21):999-1003. PubMed ID: 3873632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?
    Kallenberg CG; Wouda AA; The TH
    Neth J Med; 1984; 27(9):322-6. PubMed ID: 6334812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.